How many insider declarations has Brownell, Kenneth Alva filed?

Brownell, Kenneth Alva has filed 4 public insider declarations with SEDI.

What is Brownell, Kenneth Alva's role?

Brownell, Kenneth Alva's reported role is not specified by the regulator across the filings.

Which companies does Brownell, Kenneth Alva report trades for?

Brownell, Kenneth Alva reports trades for PharmaCorp Rx Inc..

What is Brownell, Kenneth Alva's declared buy vs sell volume?

Across the available history, declared buys total 98k€ and disposals 0.

← Executives ★ Sign in to follow

BK

Brownell, Kenneth Alva

·SEDI

PharmaCorp Rx Inc.

0

Total declarations

0

Company

€98,175

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the full record of transactions filed by Brownell, Kenneth Alva. Officer active across 1 company, notably PharmaCorp Rx Inc.. Aggregated, 4 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €98k. Activity tracked since 12 November 2025. The latest transaction was disclosed on 12 November 2025 (15 - Acquisition or disposition under a prospectus). Regulator: SEDI. All data is openly available.

Companies and markets linked to Brownell, Kenneth Alva

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

PharmaCorp Rx Inc. (CA)

Declarations4 total

●

Brownell, Kenneth Alva

4 - Director of IssuerExecutives6 Jun 2024PharmaCorp Rx Inc.

0SEDI ↗

Warrants Expiring 24 mos from Nov 12, 2025TSXSEDI:4766946

●

Brownell, Kenneth Alva

4 - Director of IssuerExecutives6 Jun 2024PharmaCorp Rx Inc.

0SEDI ↗

WarrantsTSXSEDI:4766945

▲

Brownell, Kenneth Alva

4 - Director of IssuerExecutives12 Nov 2025PharmaCorp Rx Inc.

CA$59,5000SEDI ↗

119,000 shares@ CA$0.50Warrants Expiring 24 mos from Nov 12, 2025TSXSEDI:4605667

Canonical exit: 10 Feb 2026 (T+90)

▲

Brownell, Kenneth Alva

4 - Director of IssuerExecutives12 Nov 2025PharmaCorp Rx Inc.

CA$99,9600SEDI ↗

238,000 shares@ CA$0.42Common SharesTSXSEDI:4605661

Canonical exit: 10 Feb 2026 (T+90)

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

BK

Brownell, Kenneth Alva

·SEDI

PharmaCorp Rx Inc.

0

Total declarations

0

Company

€98,175

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the full record of transactions filed by Brownell, Kenneth Alva. Officer active across 1 company, notably PharmaCorp Rx Inc.. Aggregated, 4 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €98k. Activity tracked since 12 November 2025. The latest transaction was disclosed on 12 November 2025 (15 - Acquisition or disposition under a prospectus). Regulator: SEDI. All data is openly available.